DRUG · COUNSELLING NOTES
Siltuximab
SYLVANT
Updated
New prescription
indication: _____. IV infusion q3 weeks; report fever/infection; no live vaccines; warned on allergies; serious/common AEs: infections, infusion reaction, rash; non-pharm: handwashing, balanced diet.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV infusion q3 weeks; report fever/infection; no live vaccines; warned on allergies; serious/common AEs: infections, infusion reaction, rash; non-pharm: handwashing, balanced diet.